Pav Rishiraj | Director, Head of Patient Safety & ABPI PV Expert Chair
Ipsen & ABPI

Day 1 - World Drug Safety Congress Americas 2025 @ 10:55

Track Chairperson's Opening Remarks

Attendees will gain insights into evolving global pharmacovigilance regulations, harmonization efforts, and compliance strategies across diverse markets. Through expert perspectives and case studies, they will explore how to navigate complex regulatory frameworks, align with international guidance, and implement best practices to ensure safety and compliance on a global scale.

Pav Rishiraj, Director, Head of Patient Safety & ABPI PV Expert Chair, Ipsen & ABPI

×

Pav Rishiraj / Track Chairperson's Opening Remarks

Pav Rishiraj, Director, Head of Patient Safety & ABPI PV Expert Chair,
Ipsen & ABPI

Pav is a dynamic and visionary healthcare leader, with 25 years of extensive experience across various safety (and PV) functions, which include senior management and leadership roles within the  (PV) discipline. He is recognised as a credible and respected global figure in the industry and remains...

CloseMore

Day 1 - World Drug Safety Congress Americas 2025 @ 12:20

Panel: Beyond Compliance: Redefining Global PV Partnerships for Agility, Trust, and Innovation

As pharmacovigilance becomes more global, data-rich, and digitally enabled, sponsors are rethinking what they need from their vendors—and what true partnership really means. In this forward-looking panel, we’ll explore how sponsors and service providers can move beyond transactional models toward trusted, strategic collaborations built for innovation, resilience, and shared accountability.

Topics will include:

• How global PV partnerships are evolving in the age of AI and automation
• Embedding ethics and transparency into tech-enabled workflows
• Vendor readiness and compliance in a rapidly changing regulatory landscape
• How to maintain flexibility, inspection-readiness, and quality across regions and programs

Sponsored by Med Communications, Inc.

Moderator: Maria Anitan, Global Head of Pharmacovigilance and Drug Safety, Med Communications Inc

Omar Aimer, Executive Member of ISoP and NASoP President, International Society of Pharmacovigilance (ISoP)

Pav Rishiraj, Director, Head of Patient Safety & ABPI PV Expert Chair, Ipsen & ABPI

×

Pav Rishiraj / Panel: Beyond Compliance: Redefining Global PV Partnerships for Agility, Trust, and Innovation

Pav Rishiraj, Director, Head of Patient Safety & ABPI PV Expert Chair,
Ipsen & ABPI

Pav is a dynamic and visionary healthcare leader, with 25 years of extensive experience across various safety (and PV) functions, which include senior management and leadership roles within the  (PV) discipline. He is recognised as a credible and respected global figure in the industry and remains...

CloseMore

Day 1 - World Drug Safety Congress Americas 2025 @ 13:35

Track Chairperson's Opening Remarks

Attendees will gain insights into evolving global pharmacovigilance regulations, harmonization efforts, and compliance strategies across diverse markets. Through expert perspectives and case studies, they will explore how to navigate complex regulatory frameworks, align with international guidance, and implement best practices to ensure safety and compliance on a global scale.

Pav Rishiraj, Director, Head of Patient Safety & ABPI PV Expert Chair, Ipsen & ABPI

×

Pav Rishiraj / Track Chairperson's Opening Remarks

Pav Rishiraj, Director, Head of Patient Safety & ABPI PV Expert Chair,
Ipsen & ABPI

Pav is a dynamic and visionary healthcare leader, with 25 years of extensive experience across various safety (and PV) functions, which include senior management and leadership roles within the  (PV) discipline. He is recognised as a credible and respected global figure in the industry and remains...

CloseMore

Day 2 - World Drug Safety Congress Americas @ 08:55

Keynote Panel: Regulatory Agency Innovation and Future PV Roadmaps. Where are we going?

Moderator: Pav Rishiraj, Director, Head of Patient Safety & ABPI PV Expert Chair, Ipsen & ABPI

×

Pav Rishiraj / Keynote Panel: Regulatory Agency Innovation and Future PV Roadmaps. Where are we going?

Pav Rishiraj, Director, Head of Patient Safety & ABPI PV Expert Chair,
Ipsen & ABPI

Pav is a dynamic and visionary healthcare leader, with 25 years of extensive experience across various safety (and PV) functions, which include senior management and leadership roles within the  (PV) discipline. He is recognised as a credible and respected global figure in the industry and remains...

CloseMore

Rania Mouchantaf, Executive Director, Health Canada

Alison Cave, Chief Safety Officer, Medicines and Healthcare products Regulatory Agency

×

Alison Cave / Keynote Panel: Regulatory Agency Innovation and Future PV Roadmaps. Where are we going?

Alison Cave, Chief Safety Officer,
Medicines and Healthcare products Regulatory Agency

Alison is a pharmacologist with a PhD in biochemistry. Her long career includes significant academic and regulatory experience, the latter initially at the Medicines Control Agency and then in senior roles within the Vigilance and Risk Management of Medicine Group at the Medicines and Healthcare...

CloseMore

Peter Hjelmstrom, Director and Chief Executive Officer, Uppsala Monitoring Centre

×

Peter Hjelmstrom / Keynote Panel: Regulatory Agency Innovation and Future PV Roadmaps. Where are we going?

Peter Hjelmstrom, Director and Chief Executive Officer,
Uppsala Monitoring Centre

Peter Hjelmström is the Director/CEO of Uppsala Monitoring Centre (UMC) since 2023 and he has overall responsibility for the operations of the foundation. Peter is physician and scientist, with MD and PhD degrees from Karolinska Institutet, and he did his postdoctoral fellowship at Yale...

CloseMore

Day 2 - World Drug Safety Congress Americas @ 11:10

Track Chairperson's Opening Remarks

Attendees will gain a deep understanding of how AI, machine learning, and automation are revolutionizing pharmacovigilance by streamlining case processing, enhancing signal detection, and driving operational efficiency. They will explore real-world applications, innovative tools, and forward-looking strategies to build trust in AI and future-proof safety operations across the drug development lifecycle.

Pav Rishiraj, Director, Head of Patient Safety & ABPI PV Expert Chair, Ipsen & ABPI

×

Pav Rishiraj / Track Chairperson's Opening Remarks

Pav Rishiraj, Director, Head of Patient Safety & ABPI PV Expert Chair,
Ipsen & ABPI

Pav is a dynamic and visionary healthcare leader, with 25 years of extensive experience across various safety (and PV) functions, which include senior management and leadership roles within the  (PV) discipline. He is recognised as a credible and respected global figure in the industry and remains...

CloseMore

Day 2 - World Drug Safety Congress Americas @ 11:55

Fireside Chat: AI, Trust, and Transformation: Separating Potential from Hype in Pharmacovigilance

This fireside chat will deliver a compelling narrative around the potential of AI based tools, focusing on the real (human) foundations of deployment like cultural change and building trust.

Beena Wood, Chief Product Officer, PV Expert

Harsha Chickballapur, Senior Director, Alnylam

×

Harsha Chickballapur / Fireside Chat: AI, Trust, and Transformation: Separating Potential from Hype in Pharmacovigilance

Harsha Chickballapur, Senior Director,
Alnylam

Experienced drug safety and regulatory systems leader with a strong track record of managing multiple software vendors and ensuring validated application states throughout the software lifecycle. Deep expertise in global regulatory requirements, including FDA, MHPD, EMA, and E2B standards for...

CloseMore

Moderator: Andrew Mitchell, Founder / CEO, Yeza.ai

Pav Rishiraj, Director, Head of Patient Safety & ABPI PV Expert Chair, Ipsen & ABPI

×

Pav Rishiraj / Fireside Chat: AI, Trust, and Transformation: Separating Potential from Hype in Pharmacovigilance

Pav Rishiraj, Director, Head of Patient Safety & ABPI PV Expert Chair,
Ipsen & ABPI

Pav is a dynamic and visionary healthcare leader, with 25 years of extensive experience across various safety (and PV) functions, which include senior management and leadership roles within the  (PV) discipline. He is recognised as a credible and respected global figure in the industry and remains...

CloseMore

Day 2 - World Drug Safety Congress Americas @ 13:50

Track Chairperson's Opening Remarks

Attendees will gain a deep understanding of how AI, machine learning, and automation are revolutionizing pharmacovigilance by streamlining case processing, enhancing signal detection, and driving operational efficiency. They will explore real-world applications, innovative tools, and forward-looking strategies to build trust in AI and future-proof safety operations across the drug development lifecycle.

Pav Rishiraj, Director, Head of Patient Safety & ABPI PV Expert Chair, Ipsen & ABPI

×

Pav Rishiraj / Track Chairperson's Opening Remarks

Pav Rishiraj, Director, Head of Patient Safety & ABPI PV Expert Chair,
Ipsen & ABPI

Pav is a dynamic and visionary healthcare leader, with 25 years of extensive experience across various safety (and PV) functions, which include senior management and leadership roles within the  (PV) discipline. He is recognised as a credible and respected global figure in the industry and remains...

CloseMore